Great West Life Assurance CO Sorrento Therapeutics, Inc. Transaction History

Great West Life Assurance CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.74 - $1.83 $5,576 - $13,790	7,536 Added 40.37%	26,202 $23,000
Q3 2022 Nov 01, 2022	BUY	$1.51 - $2.88 $28,185 - $53,758	18,666 New	18,666 $29,000
Q2 2022 Aug 09, 2022	BUY	$1.24 - $2.33 $837 - $1,572	675 Added 3.9%	17,986 $36,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $1,392 - $3,410	696 Added 4.19%	17,311 $42,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $3,027 - $4,706	651 Added 4.08%	16,615 $77,000
Q2 2021 Aug 11, 2021	BUY	$6.35 - $10.0 $165 - $260	26 Added 0.16%	15,964 $154,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $50,428 - $104,622	8,755 Added 121.89%	15,938 $108,000
Q3 2020 Nov 17, 2020	SELL	$6.17 - $18.82 $104,050 - $317,380	-16,864 Reduced 70.13%	7,183 $80,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $104,050 - $317,380	16,864 Added 234.78%	24,047 $268,000
Q2 2020 Aug 17, 2020	BUY	$1.73 - $6.76 $12,426 - $48,557	7,183 New	7,183 $45,000
Q4 2019 Feb 11, 2020	SELL	$1.45 - $4.17 $7,519 - $21,625	-5,186 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$2.05 - $2.69 $9,405 - $12,341	-4,588 Reduced 46.94%	5,186 $11,000
Q2 2018 Aug 10, 2018	BUY	$4.75 - $8.0 $46,426 - $78,192	9,774 New	9,774 $69,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.